封面
市場調查報告書
商品編碼
1386337

全球心率管理設備市場:趨勢、預測與競爭分析(~2030 年)

Cardiac Rhythm Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

心率管理設備的趨勢和預測

預計2030年,全球心率管理設備市場規模將達到約193億美元,2024年至2030年年複合成長率為4.5%。該市場的主要促進因素是心血管疾病盛行率的上升、人們對心率管理設備益處的認知不斷提高,以及技術的不斷進步,導致更有效、侵入性更小的新型創新設備正在開發中。全球心率管理設備市場的未來充滿希望,醫院/診所和門診手術中心市場充滿機會。

心率管理設備市場洞察

Lucintel 預測,由於院外心臟麻痹率不斷上升,心臟去顫器在預測期內仍將是最大的細分市場。

在這個市場中,醫院和診所預計仍將是最大的部分。

由於老年人口的快速成長和先進的醫療保健系統的存在,北美仍然是最大的地區。

市場規模/估算:心率管理設備的金額規模估算(10 億美元)

趨勢和預測分析:各細分市場和地區的市場趨勢(2018-2023)和預測(2024-2030)

細分市場分析:按產品類型、最終用途和金額區域估算心率管理設備的市場規模(十億美元)

區域分析:北美、歐洲、亞太地區和世界其他地區心率

成長機會:心率管理設備市場按產品類型、最終用途和地區分類的成長機會分析

策略分析:包括心率管理設備市場併購、新產品開發、競爭形勢等

基於波特五力模型的產業競爭實力分析

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球心率管理設備市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球心率管理設備市場趨勢(2018-2023)與預測(2024-2030)
  • 全球心率管理設備市場:依產品類型
    • 心臟起搏器
    • 心臟去顫器
    • 心臟再同步治療裝置
  • 全球心率管理設備市場:依最終用途分類
    • 醫院/診所
    • 門診手術中心
    • 其他

第4章 市場趨勢與預測分析:按地區(2018-2030)

  • 全球心率管理設備市場:按地區
  • 北美心率管理設備市場
  • 歐洲心率管理設備市場
  • 亞太心率管理設備市場
  • 其他地區心率管理設備市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球心率管理設備市場成長機會
    • 全球心率管理設備市場成長機會(依最終用途)
    • 按地區分類的全球心率管理設備市場成長機會
  • 全球心率管理設備市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球心率管理設備市場的產能
    • 全球心率管理設備市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Physio-Control
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips
  • BIOTRONIK
  • Progetti
  • Zoll Medical Corporation
  • LivaNova
簡介目錄

Cardiac Rhythm Management Devices Trends and Forecast

The future of the global cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets. The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.

A more than 150-page report is developed to help in your business decisions.

Cardiac Rhythm Management Devices by Segment

The study includes a forecast for the global cardiac rhythm management devices by product type, end use, and region.

Cardiac Rhythm Management Devices Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiac Pacemakers
  • Defibrillators
  • Cardiac Resynchronization Therapy Devices

Cardiac Rhythm Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Cardiac Rhythm Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cardiac Rhythm Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac rhythm management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac rhythm management devices companies profiled in this report include-

  • Physio-Control
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips
  • Biotronik
  • Progetti
  • Zoll Medical Corporation
  • Livanova

Cardiac Rhythm Management Devices Market Insights

Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.

Within this market, hospitals and clinics is expected to remain the largest segment.

North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.

Features of the Global Cardiac Rhythm Management Devices Market

Market Size Estimates: Cardiac rhythm management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac rhythm management devices market size by product type, end use, and region in terms of value ($B).

Regional Analysis: Cardiac rhythm management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the cardiac rhythm management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac rhythm management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cardiac rhythm management devices market size?

Answer: The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030.

Q.2 What is the growth forecast for cardiac rhythm management devices market?

Answer: The global cardiac rhythm management devices market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cardiac rhythm management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.

Q4. What are the major segments for cardiac rhythm management devices market?

Answer: The future of the cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets.

Q5. Who are the key cardiac rhythm management devices market companies?

Answer: Some of the key cardiac rhythm management devices companies are as follows:

  • Physio-Control
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips
  • Biotronik
  • Progetti
  • Zoll Medical Corporation
  • Livanova

Q6. Which cardiac rhythm management devices market segment will be the largest in future?

Answer: Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.

Q7. In cardiac rhythm management devices market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cardiac rhythm management devices market by product type (cardiac pacemakers, defibrillators, and cardiac resynchronization therapy devices), end use (hospitals & clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Rhythm Management Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cardiac Rhythm Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cardiac Rhythm Management Devices Market by Product Type
    • 3.3.1: Cardiac Pacemakers
    • 3.3.2: Defibrillators
    • 3.3.3: Cardiac Resynchronization Therapy Devices
  • 3.4: Global Cardiac Rhythm Management Devices Market by End Use
    • 3.4.1: Hospitals & Clinics
    • 3.4.2: Ambulatory Surgery Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cardiac Rhythm Management Devices Market by Region
  • 4.2: North American Cardiac Rhythm Management Devices Market
    • 4.2.2: North American Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
  • 4.3: European Cardiac Rhythm Management Devices Market
    • 4.3.1: European Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
    • 4.3.2: European Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Cardiac Rhythm Management Devices Market
    • 4.4.1: APAC Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
    • 4.4.2: APAC Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Cardiac Rhythm Management Devices Market
    • 4.5.1: ROW Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
    • 4.5.2: ROW Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by End Use
    • 6.1.3: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by Region
  • 6.2: Emerging Trends in the Global Cardiac Rhythm Management Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cardiac Rhythm Management Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Rhythm Management Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Physio-Control
  • 7.2: Medtronic
  • 7.3: Abbott
  • 7.4: Boston Scientific Corporation
  • 7.5: Schiller
  • 7.6: Koninklijke Philips
  • 7.7: BIOTRONIK
  • 7.8: Progetti
  • 7.9: Zoll Medical Corporation
  • 7.10: LivaNova